Champions Oncology, Inc. (CSBR)
Nasdaq: CSBR · Biological Products, (No Diagnostic Substances) · Baltimore, MD · filing with the SEC since 1995
Filings
137 filings since 2017 beside 120 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Oct 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Dec 15, 2026
10-K
Annual report for the fiscal year ending Apr 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Jul 29, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Aug 28, 2026.
Filings a yearinsider forms included
2234221741322318
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Mar 30, 2026.SEC letters: 3 in the last 36 months, the newest Mar 4, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
40 of 137 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.